Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer

被引：3
|
作者：
Zhao, Zhengyi [1 ]
Cai, Shangli [1 ]
Wang, Zhijie [2 ]
机构：
[1] 3D Med Inc, Med Dept, Shanghai, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Pan Jia Yuan S Ln, Beijing 100021, Peoples R China
来源：
JAMA ONCOLOGY | 2020年 / 6卷 / 06期
关键词：
D O I：
10.1001/jamaoncol.2020.0283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：932 / 932
页数：1
相关论文
共 50 条
  • [41] Tumor budding as a prognostic marker in stage III colorectal carcinoma
    Choi, H. J.
    Park, K. J.
    Shin, J. S.
    Roh, M. S.
    Kwon, H. C.
    Lee, H. S.
    ISUCRS: PROCEEDINGS OF THE XXI BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS, 2006, : 61 - +
  • [42] Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
    Lin, Po-Han
    Wang, Ming-Yang
    Lo, Chiao
    Tsai, Li-Wei
    Yen, Tzu-Chun
    Huang, Thomas Yoyan
    Huang, Wei-Chih
    Yang, Karen
    Chen, Chih-Kai
    Fan, Sheng-Chih
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Prognostic utility of circulating tumor DNA methylation analysis in stage IV colorectal cancer
    Momose, Hirotaka
    Sugimoto, Kiichi
    Irie, Takahiro
    Nomura, Sachio
    Ro, Hisashi
    Ishiyama, Shun
    Takahashi, Makoto
    Pisanic, Thomas
    Sakamoto, Kazuhiro
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [44] Prognostic value of baseline circulating tumor cells (CTCs) enumerations is for stage III and stage IV breast cancer
    Zhang, Qiang
    Cai, Zheng
    Gerratana, Lorenzo
    D'Amico, Paolo
    Davis, Andrew A.
    Jacob, Saya Liz
    Vagia, Elena
    Shah, Ami N.
    Flaum, Lisa
    Zhang, Youbin
    Qiang, Wenan
    Wehbe, Firas
    Behdad, Amir
    Gradishar, William
    Platanias, Leonidas C.
    Cristofanilli, Massimo
    CANCER RESEARCH, 2021, 81 (04)
  • [45] Circulating tumor cells as prognostic marker in metastatic breast cancer
    Andreopoulou, Eleni
    Cristofanilli, Massimo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 171 - 177
  • [46] CIRCULATING TUMOR DNA MAY GUIDE ADJUVANT TREATMENT DECISIONS IN STAGE II COLON CANCER
    Gambardella, V.
    Martinelliy, E.
    Tarazona, N.
    Cervantes, A.
    ESMO OPEN, 2022, 7 (04)
  • [47] Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer
    Li, Ning
    Wang, Bao-Xiao
    Li, Jian
    Shao, Yang
    Li, Ming-Tian
    Li, Jian-Jun
    Kuang, Peng-Peng
    Liu, Zui
    Sun, Tian-Yu
    Wu, Hui-Qi
    Ou, Wei
    Wang, Si-Yu
    CANCER, 2022, 128 (04) : 708 - 718
  • [48] Evaluation of the DCC protein expression as a prognostic marker in stage III colon carcinoma
    Haack, GA
    Klump, B
    Gaco, V
    Gregor, M
    Porschen, R
    GASTROENTEROLOGY, 1999, 116 (04) : A416 - A416
  • [49] POST-DEBULKING CIRCULATING TUMOR CELL AS A POOR PROGNOSTIC MARKER IN ADVANCED STAGE OVARIAN CANCER
    Lee, H. P.
    Kim, M.
    Suh, D. H.
    Bu, J.
    Kang, Y. T.
    Kim, K.
    No, J. H.
    Kim, Y. B.
    Cho, Y. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1567 - 1567
  • [50] POST-DEBULKING CIRCULATING TUMOR CELL AS A POOR PROGNOSTIC MARKER IN ADVANCED STAGE OVARIAN CANCER
    Lee, H. P.
    Kim, M.
    Suh, D. H.
    Bu, J.
    Kang, Y. T.
    Kim, K.
    No, J. H.
    Kim, Y. B.
    Cho, Y. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 305 - 305
12345